SUMOylation of ATRIP potentiates DNA damage signaling by boosting multiple protein interactions in the ATR pathway

Area of Science:

• Molecular Biology
• Cellular Biology
• Biochemistry

Background:

• The ATM and Rad3-related (ATR) pathway is a critical DNA damage response (DDR) signaling cascade.
• While ATR-Chk1 kinase signaling is well-established, the role of other post-translational modifications in the ATR pathway is largely unexplored.

Purpose of the Study:

• To investigate the role of protein SUMOylation in the ATR DNA damage signaling pathway.
• To determine if SUMOylation of ATRIP, the ATR pathway's regulatory partner, impacts ATR pathway function.

Main Methods:

• Site-directed mutagenesis to create an ATRIP SUMOylation mutant.
• Immunofluorescence to assess ATRIP localization at DNA damage sites.
• Co-immunoprecipitation assays to evaluate protein-protein interactions within the ATR pathway.
• In vitro binding assays using SUMO2 chains.

Main Results:

• ATRIP is SUMOylated by SUMO2/3 at specific lysine residues (K234, K289).
• An ATRIP SUMOylation mutant shows impaired localization to DNA damage sites and reduced ATR activation.
• The ATRIP SUMOylation mutant exhibits decreased binding to multiple ATR pathway proteins, including ATR, RPA70, TopBP1, and the MRN complex.
• These interacting proteins show affinity for SUMO2 chains, suggesting a dual binding mechanism.

Conclusions:

• Protein SUMOylation is a key post-translational modification in the ATR DNA damage response pathway.
• ATRIP SUMOylation acts as a molecular 'glue,' enhancing interactions with multiple pathway components to promote ATR activation.
• This SUMOylation-dependent mechanism provides a novel layer of regulation for DNA damage signaling.